The efficiency of epitope-based therapeutics for specific immunotherapy was also demonstrated by using antigen-processing T-cell epitopes, so-called apitopes, as tolerogenic peptides in the context of Graves disease, multiple sclerosis, and immune tolerance induction to FVIII in hemophilia A (67–69). The gene discussed is F8; the disease is Graves disease.